health news today obesity drugs glp-1 The Access Gap: Mapping Who Can Actually Afford America's Miracle Weight-Loss Commentary: New obesity drugs face

doi: 10.1016/j.tem.2019.05.008 190 KieczykowskaMKocotJPadziorMMusikI

This proposed data collection was similar to the market-based data collection as finalized in the FY 2021 IPPS/LTCH PPS final rule (85 FR 558873 through 58892), with additional modifications to use the payer-specific negotiated charges from the hospital's most recent MRF published prior to the submission of its cost report, to reflect proposed revisions to the hospital price transparency regulations at 45 CFR 180, and to better address when the payer-specific negotiated charge is based on a percentage or algorithm, in response to previous concerns (85 FR 58884)

When you get the hydration you need intravenously, it works faster and better than when it must work its way through your digestive system first

They need different treatment plans for safe and effective care

This seemingly small chemical modification drastically alters its pharmacokinetics, making the molecule highly lipophilic (fat-soluble)